Literature DB >> 15723972

Incidence, location, magnitude, and clinical correlates of saphenous vein graft calcification: an intravascular ultrasound and angiographic study.

Marco T Castagna1, Gary S Mintz, Patrick Ohlmann, Jun-Ichi Kotani, Akiko Maehara, Natalie Gevorkian, Edouard Cheneau, Eugenio Stabile, Andrew E Ajani, William O Suddath, Kenneth M Kent, Lowell F Satler, Augusto D Pichard, Neil J Weissman.   

Abstract

BACKGROUND: The pattern of saphenous vein graft (SVG) calcification before percutaneous intervention has not been studied. METHODS AND
RESULTS: We used diagnostic and preintervention intravascular ultrasound (IVUS) to determine the incidence and magnitude of SVG calcification in 334 SVG lesions in 274 consecutive patients. Calcium was found in 133 SVGs (40%). Calcium was uniformly distributed among 48 lesion sites (14%), 43 proximal references (13%), and 42 distal references (13%). Calcium was superficial in 20 (40%) and deep in 28 (60%). Over the entire length of the SVGs, the maximum arc and length of calcium (in calcium-containing SVGs) averaged 174+/-107 degrees and 6.8+/-4.8 mm, respectively. In calcium-containing SVGs, lesion site arc and length of calcium measured 151+/-107 degrees and 4.1+/-3.7 mm, similar to the proximal and distal references (175+/-121 degrees and 4.0+/-2.3 mm and 177+/-121 degrees and 4.1+/-2.5 mm, respectively). Graft age (7.5+/-4.7 versus 10.5+/-4.7 years, P<0.0001), insulin-treated diabetes mellitus (40% versus 60%, P=0.02), and tobacco use (44% versus 55%, P=0.06) were clinical independent predictors of SVG calcification.
CONCLUSIONS: Sixty-five percent of calcium-containing SVGs had reference calcium in the absence of lesion calcium. Calcium was located primarily in SVG wall and not at the plaque. These data suggest that SVG calcium is not just part of lesion formation and maturation. SVG calcium occurred more commonly in older grafts, in insulin-treated diabetic patients, and in smokers.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15723972     DOI: 10.1161/01.CIR.0000157160.69812.55

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  11 in total

Review 1.  Tissue engineering and regenerative medicine research perspectives for pediatric surgery.

Authors:  Amulya K Saxena
Journal:  Pediatr Surg Int       Date:  2010-03-24       Impact factor: 1.827

2.  Osteoprotegerin is not associated with angiographic coronary calcification.

Authors:  Prospero B Gogo; David J Schneider; Edward F Terrien; Burton E Sobel; Harold L Dauerman
Journal:  J Thromb Thrombolysis       Date:  2006-12       Impact factor: 2.300

Review 3.  Calcium Modification Therapies in Contemporary Percutaneous Coronary Intervention.

Authors:  Mohammad Zaidan; Mohammad Alkhalil; Khaldoon Alaswad
Journal:  Curr Cardiol Rev       Date:  2022

4.  High mobility group box 1 (HMGB1) mediates high-glucose-induced calcification in vascular smooth muscle cells of saphenous veins.

Authors:  Yongyi Wang; Jianggui Shan; Wengang Yang; Hui Zheng; Song Xue
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

5.  Differential changes of aorta and carotid vasodilation in type 2 diabetic GK and OLETF rats: paradoxical roles of hyperglycemia and insulin.

Authors:  Mei-Fang Zhong; Wei-Li Shen; Masaki Tabuchi; Kyoko Nakamura; Yi-Chen Chen; Cong-Zhen Qiao; Jin He; Jie Yang; Chuan Zhang; Zdravko Kamenov; Hideaki Higashino; Hong Chen
Journal:  Exp Diabetes Res       Date:  2011-10-01

Review 6.  Current understanding of coronary artery calcification.

Authors:  Wei Liu; Yue Zhang; Cheuk-Man Yu; Qing-Wei Ji; Meng Cai; Ying-Xin Zhao; Yu-Jie Zhou
Journal:  J Geriatr Cardiol       Date:  2015-11       Impact factor: 3.327

7.  From debulking to delivery: sequential use of rotational atherectomy and Guidezilla™ for complex saphenous vein grafts intervention.

Authors:  Mariano Pellicano; Vincent Floré; Emanuele Barbato; Bernard De Bruyne
Journal:  BMC Cardiovasc Disord       Date:  2018-06-19       Impact factor: 2.298

8.  Nodular Calcification in Saphenous Vein Graft Successfully Treated by Percutaneous Coronary Intervention.

Authors:  Ko Yamamoto; Masahiro Natsuaki; Takeshi Serikawa; Masanori Okabe; Yusuke Yamamoto
Journal:  Case Rep Cardiol       Date:  2018-11-08

Review 9.  Review of risk factors, treatment, and prevention of saphenous vein graft disease after coronary artery bypass grafting.

Authors:  Jing Gao; Yin Liu; Yu-Ming Li
Journal:  J Int Med Res       Date:  2018-09-04       Impact factor: 1.671

10.  Full calcified jacket of saphenous vein graft.

Authors:  Hyun Soo Kim; Weon Kim
Journal:  Korean Circ J       Date:  2013-01-31       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.